Is Hormone Therapy Safe? What Changed in 2026
Is Hormone Therapy Safe? What Changed in 2026
Women spent decades being warned about hormones.
Meanwhile, some were barely sleeping, losing their sex drive, struggling with brain fog or wondering why they suddenly didn't feel like themselves.
A lot were told to tough it out.
Others were told the risks were too great.
Much of that fear traces back to research published in the early 2000s.
The findings mattered, but the way they shaped the conversation around menopause hormone therapy left plenty of women wondering whether treatment was even an option.
Then, in February 2026, the FDA made a significant change to the warnings on several hormone therapy products.
Does that mean hormones are suddenly risk-free? No. Does it mean it's worth taking another look at the conversation, especially if you've spent years believing HRT was automatically dangerous? Absolutely.
Here's what changed, what the research actually tells us, & what to ask before deciding whether hormone therapy might be right for you.
What Changed in February 2026?
On February 12, the FDA approved updated labeling for six menopausal hormone therapy products. The changes removed references to cardiovascular disease, breast cancer & probable dementia from the drugs' boxed warnings, the most prominent safety warnings on prescription labels.
That's a significant change. But there's an important distinction here: removing a risk from a boxed warning doesn't mean the FDA declared that risk nonexistent.
Information about cardiovascular disease & breast cancer remains in other sections of the prescribing information for systemic hormone therapy. The boxed warning about endometrial cancer also remains on systemic estrogen-only products.
In other words, the warnings are being updated to better reflect the evidence. The risks still need to be considered when making decisions about treatment.
Why Were Women Warned in the First Place?
A lot of the fear traces back to the Women's Health Initiative (WHI), a major research program that published influential findings in the early 2000s.
The studies found an increased risk of breast cancer with one estrogen-plus-progestin regimen, & an increased risk of stroke with estrogen alone. Separate WHI studies involving women aged 65–79 also found an increased risk of probable dementia when hormone therapy was used in that older population.
Those findings mattered. But the details matter, too.
The main WHI hormone trials involved women aged 50–79, with an average age of about 63. Researchers studied specific formulations, including conjugated equine estrogen & medroxyprogesterone acetate.
Those results became the basis for broad warnings that many women & clinicians understood as applying to hormone therapy across the board.
But what about a woman in her early 50s dealing with debilitating hot flashes? Or someone using low-dose vaginal estrogen for painful sex & vaginal dryness? Or a woman considering a different hormone formulation or delivery method?
Those aren't necessarily the same clinical situations.
Age, timing, medical history, formulation, dose & route of administration all matter when assessing benefits & risks.
In November 2025, the FDA requested labeling changes after reviewing additional evidence, including newer analyses & long-term follow-up data. The first six products received approved labeling changes in February 2026.
The point isn't that the original research was meaningless. It's that research needs context, & medical guidance should evolve when the evidence does.
Read the FDA's explanation of the original studies & labeling changes.
So, Who Might Benefit From HRT?
Menopausal hormone therapy is an established treatment for several symptoms & conditions, including:
-
Hot flashes & night sweats: The symptoms that can leave you waking up drenched at 3 a.m. wondering if your thermostat has personally declared war on you.
-
Vaginal dryness & painful sex: Symptoms that can affect intimacy, comfort & everyday life.
-
Certain urinary & genital symptoms: Hormone therapy, particularly local vaginal estrogen, can help with some symptoms associated with genitourinary syndrome of menopause.
-
Bone loss prevention: Certain hormone therapy products are approved to help prevent osteoporosis in appropriate patients.
For many healthy women who are younger than 60 or within 10 years of menopause, the balance of benefits & risks may be more favorable when treating bothersome menopausal symptoms.
That doesn't mean everyone needs hormones.
It doesn't mean HRT should be prescribed to prevent heart disease or dementia or that every symptom that appears in your 40s is caused by declining estrogen.
But it does mean the decision deserves an individual assessment,
not a blanket answer based on a headline from 2002
Who Should Be Cautious or May Not Be a Candidate?
Hormone therapy isn't appropriate for everyone.
Depending on the product & your medical history, it may be unsuitable if you have:
-
Unexplained vaginal bleeding
-
A history of certain hormone-sensitive cancers, including breast cancer
-
A current or previous blood clot, stroke or heart attack
-
Liver disease
This isn't a complete list & having a particular health condition doesn't always mean every type of hormone treatment is automatically off the table. It means your clinician needs to assess your specific history, the type of therapy being considered & the risks involved.
There are also important differences between hormone products.
If you still have your uterus, systemic estrogen generally needs to be paired with a progestogen.
Estrogen can cause the uterine lining to thicken, increasing the risk of endometrial cancer.
A progestogen helps protect against that.
Estrogen-only systemic therapy is generally used after hysterectomy, although individual circumstances vary.
Low-dose vaginal estrogen used for local symptoms is different from systemic hormone therapy, which delivers hormones throughout the body.
Their benefits, risks & prescribing considerations aren't identical, so don't assume information about one applies to the other.
FDA-approved hormone products that are chemically identical to hormones made by the body are available. Compounded hormone preparations are not FDA-approved & the FDA has not established that they're safer or more effective than approved alternatives.
Read the FDA's consumer guidance on hormone therapy.
Five Questions to Ask Your Provider
If you're considering HRT, start here.
You don't need to walk into an appointment knowing all the answers.
That's what the appointment is for.
1. What symptoms are we actually treating?
Hot flashes, vaginal symptoms & bone-loss prevention are different treatment goals. Be specific about what's happening, how long it's been going on & how it's affecting your life.
2. What are my individual risks?
Discuss your personal & family history, including certain cancers, blood clots, cardiovascular disease & unexplained bleeding. Your age, time since menopause & other medications matter, too.
3. Which type makes sense for me?
Ask about estrogen, progesterone or other progestogens, & whether a patch, pill, gel or vaginal product fits your symptoms & medical history. The route of administration can matter when weighing risks.
4. If I still have my uterus, do I need progesterone?
For systemic estrogen, the answer is generally yes, unless there's another appropriate plan to protect the uterine lining. Make sure you understand how that protection will be provided.
5. How will we know if it's working?
Ask what improvement you can reasonably expect, which side effects to watch for, when you'll follow up & how often your treatment should be reviewed. Your treatment plan can be reassessed as your needs change.
Women deserve a current, individual assessment of the benefits & risks of hormone therapy.
For some women, hormone therapy can make a meaningful difference to daily life.
For others, their medical history or risk profile may point toward a different treatment.
Both deserve a thoughtful conversation.
The 2026 FDA update is an important change in how these medications are labeled.
It isn't a guarantee of safety, a recommendation for every woman to start treatment or a reason to dismiss legitimate risks.
You shouldn't have to arrive at your appointment armed with research papers just to get someone to listen to your symptoms. But knowing the questions to ask can help you take a more active role in the decision.
You deserve to understand your options, ask uncomfortable questions & make an informed decision with a qualified clinician who takes your symptoms seriously.